Dr. Kurt R. Oelke, MD

Dr. Oelke practices at Rheumatic Disease Center in Milwaukee, Wisconsin.

Dr. Oelke's NPI, 1962433136, was assigned on July 6, 2006. Dr. Oelke graduated from University of Wisconsin School of Medicine in 1997. Dr. Oelke holds Wisconsin license 45274.

Dr. Oelke's primary practice is Rheumatic Disease Center, at 2500 W Layton Ave, Milwaukee, WI 53221 in Milwaukee County. The practice phone is (414) 351-4009.

Dr. Oelke's primary practice is Rheumatic Disease Center in Milwaukee, Wisconsin. Dr. Oelke is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Rheumatic Disease Center. Dmand AI also links Dr. Oelke to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oelke practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Oelke's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Oelke is licensed in Wisconsin.

CMS data shows 21,664 Medicare services from Dr. Oelke across 29 procedure codes in 2024, for 277 Medicare patients. Medicare paid $631,643 for them. Every service was in an office.

CMS counts 277 Medicare patients who saw Dr. Oelke in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have arthritis, and 72% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Oelke's median patient age at 65, with 70% women.

In 2024, Dr. Oelke wrote 4,660 Medicare Part D claims for 614 patients. 90% of them were for generic drugs. CMS names the drug for 4,349 of them, across 50 drugs with 11 or more claims each, at $2,211,448 in total drug cost. In 2023, CMS named 4,571 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Oelke for performance year 2024, reported individually. Dr. Oelke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oelke as offering telehealth.

Dmand AI links 4 papers to Dr. Oelke, published from 2019 to 2023. The most frequent topics are Antirheumatic Agents, Arthritis, Rheumatoid and Antibodies, Monoclonal, Humanized. Dr. Oelke's most frequent co-authors are Mark Christopher Genovese, MD, Alan J. Kivitz, MD and Andrew Jay Laster, MD.

Dmand AI links Dr. Oelke to 5 clinical trials, 3 of them phase 3 studies. Conditions studied include Lupus Erythematosus, Systemic, Connective Tissue Diseases and Arthritis, Rheumatoid. GlaxoSmithKline sponsors the most, 3. Open Payments lists research payments to Dr. Oelke that name 1 trial.

CMS Open Payments shows 2,157 general payments to Dr. Oelke from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Amgen Inc. paid the most, $230,698. It also lists 26 research payments totaling $26,229 from 2016 to 2023, naming 1 clinical trial.

Dr. Oelke graduated from University of Wisconsin School of Medicine in 1997.